INFOGRAPHIC: Taking The Measure Of Pfizer-Allergan
This article was originally published in Scrip
The $160bn deal that brings together Pfizer Inc. and Allergan PLC released a tidal wave of information for the pharma industry and its entourage to digest, analyze and act upon. For the benefit of time-constrained readers, Scrip has produced this infographic highlighting some of the key figures and putting the deal into context. From global employee distribution to Pfizer's US tax history, and from share prices to M&A league tables, there should be something for everyone.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.